INSM Stock Analysis: Buy, Sell, or Hold?
INSM - Insmed, Inc.
$131.10
-1.45 (-1.09%)
▼
5d:
+32.96%
30d:
+10.86%
90d:
+24.86%
HOLD
MODERATE Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 9.0/10
Get Alerted When INSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: INSM is 12.1% above its trading range ($117.00). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: INSM is 12.1% above its trading range ($117.00). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: INSM is currently trading at $131.10, which is considered extended relative to its 30-day fair value range of $100.85 to $117.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 1062.1) compared to its historical average (285.3). At these levels, the market is pricing in 55.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, INSM is in a strong downtrend. Immediate support is located at $96.42, while resistance sits at $137.70.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $195.95 (+47.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INSM is in a strong downtrend. Immediate support is located at $96.42, while resistance sits at $137.70.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $195.95 (+47.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$100.85 -
$117.00
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
INSM is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 47.8% below Wall St target ($195.95)
- BEARISH: Market expects 55.0% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$100.85 -
$117.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$96.42
Resistance Level
$137.70
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1062.10
Wall Street Target
$195.95
(+47.8%)
Revenue Growth (YoY)
229.6%
Profit Margin
-144.4%
Valuation Premium vs History
+55.0% premium
PE vs Historical
1062.1 vs 285.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+55.0%
(market-implied from PE analysis)
1-Year Target
$198.83
(+50%)
2-Year Target
$298.24
(+125%)
3-Year Target
$447.36
(+238%)
3-Yr Target (if PE normalizes)
(PE: 1062→285)
PE COMPRESSION
$120.17
(-9%)
Significant PE compression expected
Share & Embed Analysis
Last updated: August 07, 2026 4:43 PM ET
Data refreshes hourly during market hours. Next update: 5:43 PM
Data refreshes hourly during market hours. Next update: 5:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
William Lewis
SELL
10699 shares
2026-04-16
William Lewis
SELL
10699 shares
2026-04-06
Roger Adsett
SELL
88060 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 55 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 56 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 57 HOLD |
Advanced INSM Option Strategies
Professional options setups generated by AI based on today's INSM price and gamma walls.
